Cleared Traditional

K132816 - ONCENTRA BRACHY

K132816 is an FDA 510(k) clearance for ONCENTRA BRACHY, manufactured by Nucletron B.V.. The device is a Class 2 Radiology device with product code MUJ cleared through the Traditional 510(k) pathway after a 277-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
277d
Days
Class 2
Risk

K132816 is an FDA 510(k) clearance for the ONCENTRA BRACHY. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Nucletron B.V. (Rice Lake, US). The FDA issued a Cleared decision on June 13, 2014 after a review of 277 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Nucletron B.V. devices

FDA 510(k) Submission Details - K132816

510(k) Number K132816 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 2013
Decision Date June 13, 2014
Days to Decision 277 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
170d slower than avg
Panel avg: 107d · This submission: 277d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MUJ Device Classification - Class 2, Special Controls

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 146
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K132816.
RT ELEMENTS, DOSE REVIEW, BRAIN METASTASES, ADAPTIVE HYBRID SURGERY ANALYSIS
K142108 · Brainlab AG · Dec 2014
SMART SEGMENTATION KNOWLEDGE BASED CONTOURING
K141248 · Varian Medical Systems, Inc. · Sep 2014
ECLIPSE TREATMENT PLANNING SYSTEM
K141283 · Varian Medical Systems, Inc. · Aug 2014
ECLIPSE TREATMENT PLANNING SYSTEM
K133247 · Varian Medical Systems, Inc. · Feb 2014
4D INTEGRATED TREATMENT CONSOLE
K133331 · Varian Medical Systems, Inc. · Jan 2014
ECLIPSE TREATMENT PLANNING SYSTEM
K131891 · Varian Medical Systems, Inc. · Sep 2013